Navigation Links
Webcast Alert: Transgenomic Inc. Announces Third Quarter 2008 Earnings Release Conference Call Webcast
Date:10/22/2008

OMAHA, Neb., Oct. 22 /PRNewswire-FirstCall/ -- Transgenomic Inc. (OTC Bulletin Board: TBIO) announces the following Webcast:

What: Transgenomic Inc. Third Quarter 2008 Earnings Release

Conference Call

When: Wednesday, October 29, 2008 @ 5:00 p.m. Eastern

Where: http://www.transgenomic.com/events.asp?id=6

How: Live over the Internet -- Simply log on to the web at the

address above.

Contact: Investor Relations, 402-452-5400

To access the call via telephone, call 800-862-9098 or 785-424-1051. A replay of the call will be available via telephone until 11:59 pm ET on Wednesday, November 12, 2008. To access, dial 888-566-0849 or 402-220-0428.

About Transgenomic:

Transgenomic is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. Specific offerings include WAVE(R) DHPLC Systems, related consumables and assay kits, cytogenetics automated systems, Transgenomic Molecular Clinical Reference Laboratory and Pharmacogenomics Research Services. Transgenomic's two laboratory services divisions utilize these technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 validated diagnostic tests to meet the needs of pharmaceutical and biotech companies, research and clinical laboratories, physicians and patients. For more information about the innovative systems, products and services offered by Transgenomic, please visit: http://www.transgenomic.com.


'/>"/>
SOURCE Transgenomic Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amgen Announces Webcast of 2008 Third Quarter Financial Results
2. Amylin Pharmaceuticals to Webcast Third Quarter Results
3. VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Conference
6. Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
7. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results
8. Palatin Technologies, Inc. Revised Call-In Number for Teleconference and Webcast to be held on September 30, 2008
9. Gen-Probe to Webcast Presentation at the UBS Global Life Sciences Conference
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at UBS Conference
11. Webcast Alert: Neogen Corporation to Announce 1st Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... July 14, 2014 Cloud Pharmaceuticals, Inc., ... and development, announced today the expansion of its ... been granted supercomputing time at Argonne National Laboratory ... Through a discretionary allocation of 1 ... (ALCF), researchers at Cloud Pharmaceuticals will use Mira, ...
(Date:7/14/2014)... Throughout this past June 100s of ... space, representing 38 countries globally, registered for Xtalks ... Participation in Clinical Trials. Attract. Engage. Retain.” , ... R&D expert, Ken Getz, of Tufts CSDD, who ... through Patient Centricity. , Throughout this complimentary six-part ...
(Date:7/14/2014)... 2014 Minerva Neurosciences (NASDAQ: NERV ... to treat neuropsychiatric diseases and disorders, today announced that ... president of finance and chief accounting officer, effective June ... executive with more than 20 years of experience in ... companies. His background includes the management of compliance and ...
(Date:7/14/2014)... San Mateo, CA (PRWEB) July 14, 2014 ... groundbreaking CONNECT patient registry platform, announced that ... Becker muscular dystrophies; the Phelan-McDermid Syndrome International ... primary Nephrotic Syndrome—have been awarded contracts by ... part of the creation of a new ...
Breaking Biology Technology:Cloud Pharmaceuticals Granted 1M Hours of Supercomputer Time to Target Orphan Diseases Including Malaria 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 5Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3
... ... Hermes Biosciences and partnership with sanofi-aventis , ... Cambridge, MA (PRWEB) April 7, 2010 -- Merrimack Pharmaceuticals, Inc., ... for cancer and inflammation, today announced that William Sullivan has been promoted to Vice ...
... have found a way to turn a precision measurement device ... researchers adapted a device known as an optical frequency comb ... data operations that will be vital for future quantum computers. ... Review Letters and is described in a Viewpoint article ...
... ... to build and sell "Flexible Fuel" cars, as would be required by ... the impact of the stricter fuel efficiency standards announced today by President ... President,s announcement, advocates of energy independence challenged the President to show his ...
Cached Biology Technology:Merrimack Pharmaceuticals Promotes William Sullivan to Vice President of Finance 2Challenge President to Adopt Energy Measure with Double the Impact of Improved Auto Fuel Efficiency Standards at Fraction of the Cost 2
(Date:7/14/2014)... news release is available in German . ... segmental patterns that manifest themselves during development. One classical ... precursors of the backbone, a process that has been ... embryo the "segmentation clock". Until now, this patterning ... time scale of genetic oscillations that periodically trigger new ...
(Date:7/14/2014)... July 14, 2014 MedNet Solutions ... in clinical study management systems, is pleased to ... equity firm focused on software-as-a-service (SaaS) and Internet-based ... MedNet Solutions.  This funding, representing the first major ... instrumental in supporting the ongoing growth and development ...
(Date:7/14/2014)... 14, 2014 Research and Markets has ... 2014: Applications for Microfluidic Technologies" report to their offering. ... testing based on microfluidic technology is expected to grow sharply, ... CAGR 2014 - 2019 of 23%. Major diagnostics companies (Alere, ... etc.) have realized the potential of rapid molecular diagnostic testing. ...
Breaking Biology News(10 mins):Timing is not only ticking 2Timing is not only ticking 3Arrowroot Capital Invests $4 Million In MedNet Solutions 2Arrowroot Capital Invests $4 Million In MedNet Solutions 3Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report 2Applications for Microfluidic Technologies in Point of Care Testing: 2014 Report 3
... in decks, utility poles and fences will likely leach ... groundwater, according to two research papers published online Wednesday. ... of Florida and Florida International University examined arsenic leaching ... real deck as well as from simulated landfills. , ...
... using MRI to detect magnetic probes of tiny iron ... time has successfully tracked immune-stimulating cells implanted into cancer ... the eight patients, MRI revealed that the implanted cells ... for treatment," says Jeff Bulte, Ph.D., an associate professor ...
... chicken when she crossed the road is less important that what ... , Organic arsenic is fed to poultry to prevent bacterial infections ... up by the tissue and the majority of it is excreted ... urine from under poultry houses -- is rich in nitrogen and ...
Cached Biology News:Researchers: Treated wood poses long-term threat 2Researchers: Treated wood poses long-term threat 3Magnetic probe successfully tracks implanted cells in cancer patients 2Magnetic probe successfully tracks implanted cells in cancer patients 3Geoscientists follow arsenic from chicken feed to streambeds 2
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
WTAP Antibody...
Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
... Rabbit polyclonal to MSY2/YBOX2 ( Abpromise ... Antigen: Synthetic peptide ... the C-terminus of Human MSY2/YBOX2. ... proprietary) (Peptide available ...
Biology Products: